Free Trial

Standex International (SXI) Financials

Standex International logo
$253.35 -1.66 (-0.65%)
Closing price 05/13/2026 03:59 PM Eastern
Extended Trading
$252.90 -0.45 (-0.18%)
As of 04:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Standex International

Annual Income Statements for Standex International

This table shows Standex International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
55 52 47 37 68 20 36 61 139 73 56
Consolidated Net Income / (Loss)
55 52 47 37 68 20 36 61 139 73 58
Net Income / (Loss) Continuing Operations
55 52 39 30 48 41 39 61 139 74 58
Total Pre-Tax Income
76 69 51 68 67 54 53 81 164 95 69
Total Operating Income
79 70 57 78 79 61 59 88 171 102 94
Total Gross Profit
247 252 216 226 235 215 241 270 285 282 315
Total Revenue
772 752 648 596 640 605 656 735 741 721 790
Operating Revenue
772 752 648 596 640 605 656 735 741 721 790
Total Cost of Revenue
525 499 432 370 405 389 415 465 456 439 475
Operating Cost of Revenue
525 499 432 370 405 389 415 465 456 439 475
Total Operating Expenses
169 182 159 148 155 155 182 182 114 181 222
Selling, General & Admin Expense
166 170 145 141 150 148 163 170 172 170 193
Other Operating Expenses / (Income)
-0.44 7.46 0.00 0.00 0.50 0.00 0.00 5.75 -63 0.11 0.00
Restructuring Charge
3.44 4.23 14 7.18 4.36 6.43 4.41 6.02 4.39 11 28
Total Other Income / (Expense), net
-2.53 -1.82 -5.96 -9.75 -13 -6.45 -6.47 -7.01 -7.14 -6.34 -25
Interest Expense
3.16 2.87 4.04 8.03 11 7.48 5.99 5.87 5.41 4.54 24
Other Income / (Expense), net
0.63 1.05 -1.92 -1.72 -1.74 1.02 -0.47 -1.13 -1.74 -1.80 -0.81
Income Tax Expense
21 16 12 38 19 13 14 20 25 22 11
Net Income / (Loss) Discontinued Operations
-0.50 -0.17 7.41 6.24 20 -21 -2.07 -0.09 -0.16 -0.52 -0.04
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - - - - - 0.00 0.00 1.92
Basic Earnings per Share
$4.33 $4.11 $3.68 $2.88 $5.40 $1.64 $3.00 $5.13 $11.77 $6.22 $4.68
Weighted Average Basic Shares Outstanding
12.66M 12.68M 12.67M 12.70M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M
Diluted Earnings per Share
$4.27 $4.08 $3.65 $2.86 $5.38 $1.63 $2.97 $5.06 $11.58 $6.14 $4.64
Weighted Average Diluted Shares Outstanding
12.66M 12.68M 12.67M 12.70M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M
Weighted Average Basic & Diluted Shares Outstanding
12.66M 12.68M 12.67M 12.70M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M
Cash Dividends to Common per Share
$0.46 - - $0.70 $0.78 $0.86 $0.94 $1.02 $1.10 $1.18 $0.94

Quarterly Income Statements for Standex International

This table shows Standex International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
19 19 16 20 18 0.86 22 15 15 2.12 67
Consolidated Net Income / (Loss)
19 19 16 20 18 1.28 23 15 16 21 69
Net Income / (Loss) Continuing Operations
19 19 16 20 18 1.29 23 15 16 21 69
Total Pre-Tax Income
25 24 20 26 23 2.00 18 26 21 27 83
Total Operating Income
27 26 22 27 24 8.46 26 35 30 36 91
Total Gross Profit
73 72 68 69 70 71 82 91 90 92 92
Total Revenue
185 178 177 180 170 190 208 222 217 221 225
Operating Revenue
185 178 177 180 170 190 208 222 217 221 225
Total Cost of Revenue
112 107 109 111 100 118 125 131 127 129 133
Operating Cost of Revenue
112 107 109 111 100 118 125 131 127 129 133
Total Operating Expenses
46 46 46 42 46 63 56 57 61 57 1.11
Selling, General & Admin Expense
44 43 42 41 43 46 52 53 54 56 52
Other Operating Expenses / (Income)
-0.27 0.00 0.11 0.27 - - - - - - -57
Restructuring Charge
2.41 2.56 4.57 1.29 2.93 17 4.13 3.96 6.43 1.06 5.50
Total Other Income / (Expense), net
-2.12 -1.35 -1.58 -1.57 -0.95 -6.47 -8.67 -8.65 -8.65 -8.40 -8.16
Interest Expense
1.28 1.02 0.95 1.30 0.98 5.58 8.36 9.02 8.91 7.91 7.33
Other Income / (Expense), net
-0.85 -0.33 -0.63 -0.27 0.03 -0.89 -0.31 0.36 0.27 -0.49 -0.83
Income Tax Expense
5.90 5.41 4.33 5.89 4.96 0.71 -5.20 11 5.17 6.54 14
Net Income / (Loss) Discontinued Operations
-0.08 -0.20 -0.14 -0.10 0.01 -0.01 -0.05 0.01 -0.03 0.05 -0.12
Net Income / (Loss) Attributable to Noncontrolling Interest
- 0.00 0.00 - 0.00 0.42 0.85 - 0.74 19 1.54
Basic Earnings per Share
$1.60 $1.60 $1.34 $1.68 $1.54 $0.07 $1.83 $1.24 $1.26 $0.17 $5.56
Weighted Average Basic Shares Outstanding
11.74M 11.79M 11.77M 11.85M 11.79M 11.94M 11.99M 12.07M 12.01M 12.04M 12.05M
Diluted Earnings per Share
$1.58 $1.59 $1.33 $1.64 $1.53 $0.07 $1.81 $1.23 $1.25 $0.17 $5.55
Weighted Average Diluted Shares Outstanding
11.93M 11.86M 11.85M 11.85M 11.90M 12.03M 12.06M 12.07M 12.05M 12.06M 12.06M
Weighted Average Basic & Diluted Shares Outstanding
11.90M 11.87M 11.85M 11.85M 12.08M 11.90M 12.07M 12.07M 12.12M 12.12M 12.11M
Cash Dividends to Common per Share
$0.28 $0.30 $0.30 $0.30 $0.30 $0.32 $0.32 - $0.32 $0.34 $0.34

Annual Cash Flow Statements for Standex International

This table details how cash moves in and out of Standex International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents
22 26 -33 21 -16 26 18 -32 91 -42 -50
Net Cash From Operating Activities
64 80 63 65 73 47 84 78 91 93 70
Net Cash From Continuing Operating Activities
66 81 51 52 73 55 82 78 91 93 70
Net Income / (Loss) Continuing Operations
55 52 39 30 48 41 39 61 139 74 58
Consolidated Net Income / (Loss)
55 52 47 37 68 20 36 61 139 73 58
Net Income / (Loss) Discontinued Operations
-0.50 -0.17 7.41 6.24 20 -21 -2.07 -0.09 -0.16 -0.52 -0.04
Depreciation Expense
17 18 18 25 29 32 33 30 28 28 35
Non-Cash Adjustments To Reconcile Net Income
1.51 14 6.44 3.04 4.02 6.11 22 12 -51 9.69 8.58
Changes in Operating Assets and Liabilities, net
-7.27 -3.04 -13 -6.46 -8.89 -25 -12 -25 -26 -18 -32
Net Cash From Discontinued Operating Activities
-2.13 -0.90 13 13 0.42 -7.44 1.72 -0.42 0.03 -0.69 -0.05
Net Cash From Investing Activities
-79 -29 -179 -32 -50 -0.62 -39 -31 42 -62 -503
Net Cash From Continuing Investing Activities
-79 -32 -178 -29 -158 -21 -39 -31 42 -62 -503
Purchase of Property, Plant & Equipment
-23 -18 -25 -24 -33 -22 -22 -24 -24 -20 -28
Acquisitions
-57 -14 -154 -10 -128 -0.62 -27 -13 0.00 -49 -479
Sale of Property, Plant & Equipment
0.07 0.38 1.11 2.85 3.16 0.18 0.12 1.82 1.74 0.00 0.44
Divestitures
- - - - 0.00 0.00 12 0.00 67 7.77 0.00
Other Investing Activities, net
1.13 -0.42 0.11 1.82 -0.38 1.34 -1.73 4.01 -2.93 -0.27 3.36
Net Cash From Discontinued Investing Activities
0.00 2.80 -0.99 -2.97 108 20 0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
45 -21 85 -12 -38 -19 -32 -69 -40 -69 380
Net Cash From Continuing Financing Activities
45 -21 85 -12 -38 -19 -32 -69 -40 -69 380
Repayment of Debt
-217 -75 -164 -165 -237 -105 -17 -25 -226 -25 -389
Repurchase of Common Equity
-10 -5.64 -7.81 -2.65 -33 -10 -21 -31 -26 -32 -9.91
Payment of Dividends
-5.82 -6.85 -7.85 -8.89 -9.83 -11 -11 -12 -13 -14 -15
Issuance of Debt
275 65 264 164 242 107 17 0.00 225 0.00 792
Issuance of Common Equity
0.70 0.94 0.85 0.92 1.13 1.74 1.27 1.42 1.34 1.53 2.23
Other Financing Activities, net
2.09 0.80 0.00 0.00 -0.91 -0.87 -0.36 -2.17 -1.17 0.00 0.00
Other Net Changes in Cash
- - - 0.29 - -1.98 4.80 - - - 3.69
Cash Interest Paid
2.55 2.35 3.26 6.18 9.47 6.32 4.90 4.75 4.23 4.09 21
Cash Income Taxes Paid
13 25 20 22 24 19 17 18 26 28 28

Quarterly Cash Flow Statements for Standex International

This table details how cash moves in and out of Standex International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-69 16 -3.63 15 10 -43 -11 -5.27 -5.89 -1.66 6.73
Net Cash From Operating Activities
16 24 24 29 18 9.06 9.54 33 17 21 12
Net Cash From Continuing Operating Activities
16 24 24 29 18 9.12 9.55 33 17 21 12
Net Income / (Loss) Continuing Operations
19 19 16 20 18 1.29 23 15 16 21 69
Consolidated Net Income / (Loss)
19 19 16 20 18 1.28 23 15 16 21 69
Net Income / (Loss) Discontinued Operations
-0.08 -0.20 -0.14 -0.10 0.01 -0.01 -0.05 0.01 -0.03 0.05 -0.12
Depreciation Expense
7.08 6.89 7.18 6.99 7.06 8.51 9.74 10 9.82 9.98 9.45
Non-Cash Adjustments To Reconcile Net Income
2.32 -13 4.25 0.54 -4.32 0.71 -22 34 -7.55 -8.40 -64
Changes in Operating Assets and Liabilities, net
-12 10 -2.92 1.51 -3.38 -1.39 -1.39 -26 -1.29 -1.51 -2.56
Net Cash From Discontinued Operating Activities
-0.23 -0.20 -0.08 -0.19 0.03 -0.06 -0.01 -0.01 0.02 -0.15 -0.16
Net Cash From Investing Activities
-33 -4.25 -16 -7.67 -6.31 -423 -64 -10 -6.36 -7.73 62
Net Cash From Continuing Investing Activities
-33 -4.25 -16 -7.67 -6.31 -423 -64 -10 -6.36 -7.73 62
Purchase of Property, Plant & Equipment
-4.34 -4.25 -5.18 -6.53 -6.73 -6.97 -6.07 -8.58 -6.42 -7.66 -5.59
Other Investing Activities, net
0.00 - -0.27 - 0.41 3.49 -0.10 -0.44 0.06 -0.06 -0.42
Net Cash From Financing Activities
-50 -7.62 -8.53 -3.37 -6.27 376 41 -31 -15 -15 -67
Net Cash From Continuing Financing Activities
-50 -7.62 -8.53 -3.37 -6.27 376 41 -31 -15 -15 -67
Repayment of Debt
-25 - - - 0.00 -339 -23 -27 -8.00 -18 -79
Repurchase of Common Equity
-22 -4.49 -5.13 -0.04 -4.38 -5.20 - -0.32 -3.74 -0.06 -0.00
Payment of Dividends
-3.29 -3.55 -3.54 -3.53 -3.53 -3.83 -3.84 -3.84 -4.56 -4.97 -4.93
Issuance of Debt
- - - - - - 68 - - - 17
Other Financing Activities, net
- - - - 1.64 - - - 0.81 0.39 0.25
Other Net Changes in Cash
- - - - 5.40 -5.70 1.64 2.35 -0.86 0.15 -0.63
Cash Interest Paid
1.28 0.94 0.86 1.01 0.90 2.66 9.68 7.92 8.73 7.90 7.51
Cash Income Taxes Paid
5.12 8.89 5.73 8.23 5.48 0.77 11 11 5.72 10 10

Annual Balance Sheets for Standex International

This table presents Standex International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Total Assets
659 690 868 917 922 931 962 934 1,025 1,005 1,567
Total Current Assets
335 356 361 384 334 332 374 379 483 430 481
Cash & Equivalents
96 122 89 110 93 119 136 105 196 154 105
Accounts Receivable
110 104 127 120 103 98 110 117 123 121 173
Inventories, net
108 105 119 104 76 85 92 105 99 87 130
Prepaid Expenses
7.07 4.78 8.40 10 22 19 24 45 34 22 14
Other Current Assets
- - - - - - - - 31 45 59
Plant, Property, & Equipment, net
109 107 133 137 134 133 133 129 131 135 160
Total Noncurrent Assets
215 228 374 396 454 466 454 427 411 440 926
Goodwill
155 157 243 212 274 271 278 268 265 281 610
Intangible Assets
38 40 103 85 119 106 99 86 76 79 226
Noncurrent Deferred & Refundable Income Taxes
0.92 11 1.14 7.45 14 17 9.57 8.19 15 17 12
Other Noncurrent Operating Assets
21 19 27 30 25 71 68 65 56 63 78
Total Liabilities & Shareholders' Equity
659 690 868 917 922 931 962 934 1,025 1,005 1,567
Total Liabilities
310 320 459 466 458 469 456 435 417 384 827
Total Current Liabilities
139 134 160 161 142 123 144 151 141 128 167
Accounts Payable
81 77 96 79 54 55 75 75 69 63 88
Accrued Expenses
48 51 59 58 50 60 62 68 62 57 63
Current Deferred & Payable Income Tax Liabilities
10 4.70 4.78 6.05 5.74 7.43 7.24 8.48 10 7.50 16
Total Noncurrent Liabilities
172 186 299 305 316 346 312 284 277 256 660
Long-Term Debt
102 92 192 194 198 199 199 175 173 149 553
Other Noncurrent Operating Liabilities
9.16 10 11 26 0.00 147 113 109 103 107 108
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - - - - 0.00 28
Total Equity & Noncontrolling Interests
349 370 409 451 464 462 506 499 607 622 712
Total Preferred & Common Equity
349 370 409 451 464 462 506 499 607 622 712
Total Common Equity
349 370 409 451 464 462 506 499 607 622 712
Common Stock
89 94 99 103 107 115 123 133 143 148 178
Retained Earnings
633 678 717 761 818 828 852 901 1,027 1,086 1,127
Treasury Stock
-281 -284 -291 -292 -324 -333 -353 -382 -404 -430 -428
Accumulated Other Comprehensive Income / (Loss)
-93 -118 -116 -122 -137 -148 -116 -153 -158 -183 -165

Quarterly Balance Sheets for Standex International

This table presents Standex International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2022 3/31/2023 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets
957 1,015 981 1,005 994 1,038 1,483 1,555 1,555 1,555 1,527
Total Current Assets
401 461 420 436 419 447 465 487 488 491 483
Cash & Equivalents
113 175 127 142 139 165 121 110 99 97 104
Accounts Receivable
120 121 127 126 121 119 153 170 167 177 180
Inventories, net
106 105 98 99 95 90 104 120 136 131 130
Prepaid Expenses
49 57 67 66 62 24 31 29 22 23 26
Other Current Assets
- - - - - 50 56 58 64 63 43
Plant, Property, & Equipment, net
130 131 129 133 135 138 138 147 160 160 153
Total Noncurrent Assets
426 424 432 436 439 452 880 921 908 903 891
Goodwill
270 269 275 280 282 292 587 611 600 594 586
Intangible Assets
82 80 84 83 82 79 208 227 218 212 205
Noncurrent Deferred & Refundable Income Taxes
7.40 9.21 14 14 15 19 22 17 12 12 9.79
Other Noncurrent Operating Assets
63 65 59 59 60 62 64 67 78 86 91
Total Liabilities & Shareholders' Equity
957 1,015 981 1,005 994 1,038 1,483 1,555 1,555 1,555 1,527
Total Liabilities
427 410 387 384 375 380 800 840 820 810 728
Total Current Liabilities
132 131 132 131 122 126 138 143 170 171 158
Accounts Payable
66 68 62 64 58 67 73 76 88 88 77
Accrued Expenses
53 56 60 56 55 53 60 59 67 69 64
Current Deferred & Payable Income Tax Liabilities
9.78 7.37 9.90 11 8.45 6.61 5.18 7.17 15 14 17
Total Noncurrent Liabilities
295 279 255 254 252 254 662 697 650 639 570
Long-Term Debt
188 173 149 149 149 149 534 579 545 535 473
Other Noncurrent Operating Liabilities
107 106 107 105 103 105 128 118 106 104 97
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - 27 28 27 45 44
Total Equity & Noncontrolling Interests
529 606 595 621 619 658 656 687 708 700 754
Total Preferred & Common Equity
529 606 595 621 619 658 656 687 708 700 754
Total Common Equity
529 606 595 621 619 658 656 687 708 700 754
Common Stock
135 139 141 143 147 150 174 177 179 182 184
Retained Earnings
933 1,010 1,043 1,058 1,070 1,101 1,098 1,116 1,138 1,136 1,199
Treasury Stock
-392 -397 -421 -425 -430 -432 -428 -428 -431 -430 -430
Accumulated Other Comprehensive Income / (Loss)
-147 -147 -168 -156 -168 -161 -188 -178 -179 -188 -199

Annual Metrics And Ratios for Standex International

This table displays calculated financial ratios and metrics derived from Standex International's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.81% -2.66% -13.80% -8.08% 7.46% -5.53% 8.55% 12.05% 0.78% -2.75% 9.64%
EBITDA Growth
13.37% -6.89% -18.51% 39.34% 5.49% -12.31% -2.04% 27.11% 69.29% -35.39% 0.08%
EBIT Growth
13.17% -9.94% -22.96% 38.94% 1.72% -20.82% -4.64% 48.51% 94.30% -41.15% -7.20%
NOPAT Growth
18.10% -6.06% -18.47% -20.63% 65.15% -19.88% -5.75% 54.33% 117.45% -45.80% -0.29%
Net Income Growth
27.71% -4.91% -10.59% -21.36% 85.54% -70.27% 80.67% 68.32% 126.40% -47.43% -21.06%
EPS Growth
27.46% -4.45% -10.54% -21.64% 88.11% -69.70% 82.21% 70.37% 128.85% -46.98% -24.43%
Operating Cash Flow Growth
-8.90% 25.43% -21.02% 2.34% 12.97% -35.59% 76.92% -7.02% 16.84% 2.04% -24.89%
Free Cash Flow Firm Growth
-19.48% 375.99% -288.31% 171.97% -134.13% 254.90% -72.78% 401.11% 93.07% -63.11% -1,132.99%
Invested Capital Growth
13.70% -4.22% 50.94% -11.37% 19.61% -0.59% 5.54% -0.04% 2.78% 5.30% 92.73%
Revenue Q/Q Growth
0.32% -0.79% -11.48% -12.00% 64.22% -18.74% 5.99% 1.14% 0.49% -1.12% 5.59%
EBITDA Q/Q Growth
5.38% -8.73% -7.15% 11.96% -3.00% -8.56% 15.34% -4.45% 5.10% -1.36% 9.72%
EBIT Q/Q Growth
5.84% -11.30% -8.27% 14.07% -6.71% -12.86% 25.22% -4.73% 6.07% -1.54% 9.72%
NOPAT Q/Q Growth
5.37% -8.01% -4.64% 7.37% 5.94% -14.11% 26.08% -1.84% 4.60% -0.29% 0.68%
Net Income Q/Q Growth
13.08% -7.45% 4.38% -4.01% -0.33% -34.34% 49.74% -1.10% 5.22% -0.78% -6.64%
EPS Q/Q Growth
13.26% -7.27% 4.29% -4.03% 0.19% -34.27% 0.00% 0.00% 3.67% 0.82% -8.12%
Operating Cash Flow Q/Q Growth
10.98% -10.08% -2.09% 6.19% 18.72% -35.90% 14.69% -3.18% 13.81% -11.41% 7.54%
Free Cash Flow Firm Q/Q Growth
167.49% -9.21% -36.08% 1,457.27% -183.69% -27.96% -48.27% 70.49% 0.52% -10.95% -3.29%
Invested Capital Q/Q Growth
-9.68% -9.52% -0.69% -18.20% -4.93% -2.99% 0.85% -4.07% -3.05% -2.03% 0.29%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
32.05% 33.56% 33.27% 37.95% 36.67% 35.64% 36.76% 36.71% 38.47% 39.13% 39.90%
EBITDA Margin
12.43% 11.89% 11.24% 17.04% 16.72% 15.52% 14.01% 15.89% 26.70% 17.74% 16.22%
Operating Margin
10.19% 9.36% 8.79% 13.12% 12.42% 10.01% 9.02% 12.01% 23.09% 14.12% 11.84%
EBIT Margin
10.27% 9.50% 8.49% 12.83% 12.15% 10.18% 8.94% 11.85% 22.85% 13.83% 11.74%
Profit (Net Income) Margin
7.09% 6.93% 7.18% 6.15% 10.61% 3.34% 5.56% 8.35% 18.76% 10.14% 7.30%
Tax Burden Percent
71.92% 75.97% 91.34% 53.52% 101.40% 37.33% 69.21% 75.52% 84.78% 76.82% 83.83%
Interest Burden Percent
96.01% 95.98% 92.65% 89.49% 86.16% 87.86% 89.79% 93.26% 96.81% 95.44% 74.20%
Effective Tax Rate
27.42% 23.78% 23.20% 55.60% 27.90% 24.15% 26.86% 24.37% 15.12% 22.64% 16.11%
Return on Invested Capital (ROIC)
17.15% 15.46% 10.27% 7.18% 11.50% 8.48% 7.80% 11.73% 25.16% 13.10% 8.70%
ROIC Less NNEP Spread (ROIC-NNEP)
36.94% 27.91% 18.06% 10.77% 37.51% -24.37% -1.83% 3.63% -0.92% 53.95% -0.69%
Return on Net Nonoperating Assets (RNNOA)
-1.26% -0.97% 1.69% 1.33% 3.35% -4.12% -0.27% 0.48% -0.04% -1.21% -0.23%
Return on Equity (ROE)
15.88% 14.49% 11.96% 8.52% 14.84% 4.36% 7.54% 12.21% 25.12% 11.89% 8.48%
Cash Return on Invested Capital (CROIC)
4.33% 19.77% -30.33% 19.24% -6.36% 9.08% 2.41% 11.77% 22.41% 7.94% -54.65%
Operating Return on Assets (OROA)
12.82% 10.58% 7.06% 8.56% 8.45% 6.64% 6.20% 9.19% 17.29% 9.82% 7.21%
Return on Assets (ROA)
8.85% 7.71% 5.97% 4.10% 7.39% 2.18% 3.85% 6.47% 14.19% 7.20% 4.49%
Return on Common Equity (ROCE)
15.88% 14.49% 11.96% 8.52% 14.84% 4.36% 7.54% 12.21% 25.12% 11.89% 8.30%
Return on Equity Simple (ROE_SIMPLE)
15.71% 14.07% 11.39% 8.12% 14.63% 4.37% 7.20% 12.29% 22.88% 11.76% 0.00%
Net Operating Profit after Tax (NOPAT)
57 54 44 35 57 46 43 67 145 79 78
NOPAT Margin
7.39% 7.13% 6.75% 5.83% 8.95% 7.59% 6.59% 9.08% 19.60% 10.92% 9.93%
Net Nonoperating Expense Percent (NNEP)
-19.80% -12.44% -7.79% -3.59% -26.01% 32.86% 9.63% 8.09% 26.07% -40.84% 9.40%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 6.21%
Cost of Revenue to Revenue
67.95% 66.44% 66.73% 62.05% 63.33% 64.36% 63.24% 63.29% 61.53% 60.87% 60.10%
SG&A Expenses to Revenue
21.48% 22.65% 22.39% 23.62% 23.49% 24.56% 24.85% 23.10% 23.26% 23.53% 24.47%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
21.87% 24.20% 24.48% 24.83% 24.25% 25.63% 27.75% 24.70% 15.38% 25.01% 28.06%
Earnings before Interest and Taxes (EBIT)
79 71 55 76 78 62 59 87 169 100 93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
96 89 73 101 107 94 92 117 198 128 128
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 2.65 2.64 2.73 1.89 1.49 2.24 2.01 2.75 3.07 2.65
Price to Tangible Book Value (P/TBV)
0.00 5.69 16.97 7.99 12.21 8.17 8.75 6.91 6.26 7.29 0.00
Price to Revenue (P/Rev)
0.00 1.30 1.66 2.07 1.37 1.14 1.73 1.37 2.26 2.65 2.39
Price to Earnings (P/E)
0.00 18.81 23.14 33.62 12.91 33.99 31.05 16.38 12.03 26.09 33.88
Dividend Yield
0.63% 0.71% 0.73% 0.73% 1.13% 1.56% 1.02% 1.22% 0.78% 0.55% 0.81%
Earnings Yield
0.00% 5.32% 4.32% 2.97% 7.74% 2.94% 3.22% 6.10% 8.31% 3.83% 2.95%
Enterprise Value to Invested Capital (EV/IC)
0.00 2.80 2.31 2.90 1.81 1.42 2.10 1.89 2.82 3.09 1.99
Enterprise Value to Revenue (EV/Rev)
0.00 1.26 1.82 2.21 1.53 1.27 1.82 1.46 2.23 2.64 2.99
Enterprise Value to EBITDA (EV/EBITDA)
0.00 10.62 16.21 12.96 9.17 8.17 13.01 9.21 8.34 14.88 18.45
Enterprise Value to EBIT (EV/EBIT)
0.00 13.29 21.46 17.21 12.62 12.45 20.37 12.34 9.74 19.08 25.50
Enterprise Value to NOPAT (EV/NOPAT)
0.00 17.70 27.00 37.90 17.13 16.70 27.63 16.11 11.36 24.16 30.13
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 11.82 18.61 20.25 13.38 16.23 14.30 13.84 18.17 20.52 33.98
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 13.84 0.00 14.15 0.00 15.60 89.42 16.06 12.75 39.85 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.29 0.25 0.47 0.43 0.43 0.43 0.39 0.35 0.29 0.24 0.75
Long-Term Debt to Equity
0.29 0.25 0.47 0.43 0.43 0.43 0.39 0.35 0.29 0.24 0.75
Financial Leverage
-0.03 -0.03 0.09 0.12 0.09 0.17 0.15 0.13 0.04 -0.02 0.33
Leverage Ratio
1.79 1.88 2.00 2.08 2.01 2.00 1.96 1.89 1.77 1.65 1.89
Compound Leverage Factor
1.72 1.80 1.85 1.86 1.73 1.76 1.76 1.76 1.71 1.58 1.40
Debt to Total Capital
22.60% 19.93% 31.96% 30.06% 29.85% 30.14% 28.26% 25.93% 22.21% 19.33% 42.76%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
22.60% 19.93% 31.96% 30.06% 29.85% 30.14% 28.26% 25.93% 22.21% 19.33% 42.76%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.16%
Common Equity to Total Capital
77.40% 80.07% 68.04% 69.94% 70.15% 69.86% 71.74% 74.07% 77.79% 80.68% 55.08%
Debt to EBITDA
1.06 1.03 2.64 1.91 1.85 2.12 2.17 1.50 0.88 1.16 4.31
Net Debt to EBITDA
0.06 -0.33 1.42 0.83 0.98 0.86 0.69 0.60 -0.11 -0.04 3.49
Long-Term Debt to EBITDA
1.06 1.03 2.64 1.91 1.85 2.12 2.17 1.50 0.88 1.16 4.31
Debt to NOPAT
1.78 1.72 4.39 5.58 3.45 4.34 4.61 2.62 1.19 1.89 7.04
Net Debt to NOPAT
0.10 -0.56 2.37 2.43 1.82 1.75 1.46 1.05 -0.15 -0.07 5.71
Long-Term Debt to NOPAT
1.78 1.72 4.39 5.58 3.45 4.34 4.61 2.62 1.19 1.89 7.04
Altman Z-Score
0.00 5.02 3.80 3.96 3.62 3.26 3.90 4.13 5.47 5.90 3.32
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.05%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.42 2.65 2.26 2.38 2.36 2.70 2.61 2.51 3.43 3.37 2.88
Quick Ratio
1.49 1.68 1.35 1.42 1.39 1.77 1.71 1.47 2.26 2.16 1.66
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
14 69 -129 93 -32 49 13 67 129 48 -493
Operating Cash Flow to CapEx
284.68% 459.84% 260.52% 313.42% 249.96% 221.37% 386.33% 352.12% 403.06% 456.48% 249.40%
Free Cash Flow to Firm to Interest Expense
4.56 23.88 -31.93 11.57 -2.95 6.57 2.23 11.41 23.93 10.50 -20.60
Operating Cash Flow to Interest Expense
20.26 27.98 15.69 8.09 6.82 6.32 13.95 13.23 16.80 20.39 2.91
Operating Cash Flow Less CapEx to Interest Expense
13.14 21.89 9.67 5.51 4.09 3.47 10.34 9.47 12.63 15.92 1.74
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.25 1.11 0.83 0.67 0.70 0.65 0.69 0.78 0.76 0.71 0.61
Accounts Receivable Turnover
7.08 7.01 5.61 4.83 5.74 6.00 6.31 6.48 6.16 5.89 5.37
Inventory Turnover
5.11 4.67 3.85 3.30 4.49 4.82 4.69 4.72 4.47 4.73 4.37
Fixed Asset Turnover
7.52 6.98 5.40 4.41 4.72 4.53 4.94 5.61 5.71 5.42 5.35
Accounts Payable Turnover
6.32 6.33 4.98 4.21 6.09 7.13 6.40 6.24 6.37 6.65 6.27
Days Sales Outstanding (DSO)
51.56 52.07 65.08 75.65 63.64 60.84 57.86 56.33 59.23 62.00 67.92
Days Inventory Outstanding (DIO)
71.44 78.11 94.90 110.48 81.33 75.67 77.80 77.33 81.60 77.24 83.44
Days Payable Outstanding (DPO)
57.73 57.70 73.28 86.65 59.96 51.18 57.03 58.54 57.29 54.91 58.17
Cash Conversion Cycle (CCC)
65.27 72.48 86.70 99.49 85.01 85.33 78.63 75.12 83.55 84.33 93.19
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
354 339 512 454 543 540 570 569 585 616 1,188
Invested Capital Turnover
2.32 2.17 1.52 1.23 1.28 1.12 1.18 1.29 1.28 1.20 0.88
Increase / (Decrease) in Invested Capital
43 -15 173 -58 89 -3.22 30 -0.22 16 31 571
Enterprise Value (EV)
0.00 949 1,180 1,315 981 767 1,196 1,076 1,650 1,901 2,365
Market Capitalization
0.00 979 1,077 1,231 877 686 1,132 1,006 1,672 1,907 1,889
Book Value per Share
$27.54 $28.89 $32.06 $35.13 $36.70 $37.20 $41.30 $41.37 $51.03 $52.43 $58.95
Tangible Book Value per Share
$12.31 $13.45 $4.98 $12.01 $5.68 $6.77 $10.56 $12.07 $22.43 $22.07 ($10.31)
Total Capital
450 462 601 645 662 661 706 674 781 770 1,292
Total Debt
102 92 192 194 198 199 199 175 173 149 553
Total Long-Term Debt
102 92 192 194 198 199 199 175 173 149 553
Net Debt
5.63 -30 103 84 104 80 63 70 -22 -5.33 448
Capital Expenditures (CapEx)
22 17 24 21 29 21 22 22 23 20 28
Debt-free, Cash-free Net Working Capital (DFCFNWC)
100 100 112 113 99 90 94 123 147 148 209
Debt-free Net Working Capital (DFNWC)
197 222 201 223 192 209 231 228 342 303 314
Net Working Capital (NWC)
197 222 201 223 192 209 231 228 342 303 314
Net Nonoperating Expense (NNE)
2.33 1.56 -2.83 -1.91 -11 26 6.80 5.39 6.22 5.63 21
Net Nonoperating Obligations (NNO)
5.63 -31 103 3.06 79 78 63 70 -22 -5.33 448
Total Depreciation and Amortization (D&A)
17 18 18 25 29 32 33 30 28 28 35
Debt-free, Cash-free Net Working Capital to Revenue
13.01% 13.27% 17.34% 18.98% 15.49% 14.94% 14.37% 16.78% 19.78% 20.58% 26.50%
Debt-free Net Working Capital to Revenue
25.46% 29.50% 31.01% 37.38% 30.04% 34.59% 35.15% 31.04% 46.19% 41.98% 39.73%
Net Working Capital to Revenue
25.46% 29.50% 31.01% 37.38% 30.04% 34.59% 35.15% 31.04% 46.19% 41.98% 39.73%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.33 $4.11 $3.68 $2.88 $5.40 $1.64 $3.00 $5.13 $11.77 $6.22 $4.68
Adjusted Weighted Average Basic Shares Outstanding
12.77M 12.78M 12.78M 12.83M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M
Adjusted Diluted Earnings per Share
$4.27 $4.08 $3.65 $2.86 $5.38 $1.63 $2.97 $5.06 $11.58 $6.14 $4.64
Adjusted Weighted Average Diluted Shares Outstanding
12.77M 12.78M 12.78M 12.83M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
12.77M 12.78M 12.78M 12.83M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M
Normalized Net Operating Profit after Tax (NOPAT)
60 57 54 60 60 51 57 71 96 87 102
Normalized NOPAT Margin
7.72% 7.56% 8.36% 10.03% 9.45% 8.40% 8.72% 9.70% 12.99% 12.06% 12.94%
Pre Tax Income Margin
9.86% 9.12% 7.87% 11.48% 10.47% 8.94% 8.03% 11.05% 22.12% 13.20% 8.71%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
25.08 24.87 13.60 9.52 7.22 8.23 9.80 14.84 31.33 21.93 3.88
NOPAT to Interest Expense
18.06 18.68 10.81 4.32 5.33 6.14 7.22 11.37 26.87 17.32 3.28
EBIT Less CapEx to Interest Expense
17.96 18.78 7.58 6.94 4.50 5.38 6.18 11.08 27.16 17.47 2.71
NOPAT Less CapEx to Interest Expense
10.94 12.59 4.79 1.74 2.60 3.29 3.61 7.61 22.70 12.85 2.11
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
10.63% 13.15% 16.87% 24.28% 14.47% 52.54% 31.39% 19.95% 9.34% 19.02% 26.06%
Augmented Payout Ratio
29.55% 23.98% 33.64% 31.53% 63.64% 104.24% 89.52% 71.14% 27.71% 62.57% 43.23%

Quarterly Metrics And Ratios for Standex International

This table displays calculated financial ratios and metrics derived from Standex International's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - 12,116,999.00 12,118,733.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 12,116,999.00 12,118,733.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.18 5.53
Growth Metrics
- - - - - - - - - - -
Revenue Growth
2.31% -5.00% -3.83% -4.32% -7.74% 6.40% 17.21% 23.23% 27.55% 16.60% 8.09%
EBITDA Growth
2.70% -7.02% -70.14% -4.94% -5.93% -50.36% 25.70% 32.43% 27.34% 180.30% 178.65%
EBIT Growth
3.16% -8.52% -75.83% -5.47% -7.46% -70.30% 22.29% 29.25% 23.92% 363.26% 246.89%
NOPAT Growth
2.58% -5.19% -79.20% -1.14% -7.68% -72.89% 98.00% -1.38% 18.00% 395.18% 121.69%
Net Income Growth
2.98% -5.85% -80.38% -2.87% -3.28% -93.24% 43.85% -20.95% -13.20% 1,522.04% 201.49%
EPS Growth
3.27% -5.92% -80.35% 3.14% -3.16% -95.60% 36.09% -25.00% -18.30% 142.86% 206.63%
Operating Cash Flow Growth
698.59% -20.77% 4.68% -29.49% 8.61% -61.56% -60.85% 17.10% -4.25% 126.96% 23.13%
Free Cash Flow Firm Growth
-160.07% -407.48% -111.28% -291.31% 17.80% -3,192.43% -6,275.87% -5,353.96% -7,137.84% 87.13% 117.65%
Invested Capital Growth
4.97% 5.77% 4.20% 5.30% 4.23% 74.83% 88.27% 92.73% 83.80% 7.91% -1.40%
Revenue Q/Q Growth
-1.89% -3.45% -0.64% 1.65% -5.40% 11.35% 9.47% 6.87% -2.08% 1.79% 1.48%
EBITDA Q/Q Growth
-6.97% -2.31% -12.34% 19.31% -7.93% -48.45% 121.97% 26.72% -12.18% 13.47% 120.66%
EBIT Q/Q Growth
-8.32% -2.19% -16.80% 26.71% -10.25% -68.61% 242.59% 35.28% -14.81% 17.34% 156.53%
NOPAT Q/Q Growth
-2.96% -1.87% -14.64% 21.62% -9.38% -71.19% 523.46% -39.42% 8.42% 20.92% 179.12%
Net Income Q/Q Growth
-6.72% 0.30% -16.28% 24.01% -7.12% -92.99% 1,682.43% -31.86% 2.00% 30.93% 231.30%
EPS Q/Q Growth
-0.63% 0.63% -16.35% 23.31% -6.71% -95.42% 2,485.71% -32.04% 1.63% -86.40% 3,164.71%
Operating Cash Flow Q/Q Growth
-60.03% 45.64% 3.40% 17.14% -38.44% -48.46% 5.32% 250.36% -49.66% 22.18% -42.86%
Free Cash Flow Firm Q/Q Growth
-264.30% -62.33% 41.95% -23.55% 29.40% -6,402.04% -12.42% -5.69% 6.31% 88.44% 254.20%
Invested Capital Q/Q Growth
5.33% 1.70% 0.34% -2.03% 4.26% 70.58% 8.06% 0.29% -0.57% 0.14% -1.27%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
39.31% 40.17% 38.52% 38.52% 41.11% 37.64% 39.67% 41.12% 41.59% 41.67% 40.93%
EBITDA Margin
17.94% 18.15% 16.02% 18.80% 18.30% 8.47% 17.18% 20.37% 18.27% 20.36% 44.28%
Operating Margin
14.57% 14.48% 12.32% 15.07% 14.14% 4.46% 12.64% 15.64% 13.63% 16.07% 40.44%
EBIT Margin
14.11% 14.29% 11.97% 14.92% 14.15% 3.99% 12.49% 15.81% 13.75% 15.85% 40.07%
Profit (Net Income) Margin
10.18% 10.58% 8.91% 10.87% 10.68% 0.67% 10.94% 6.97% 7.26% 9.34% 30.51%
Tax Burden Percent
75.88% 77.08% 77.95% 76.58% 78.60% 63.81% 129.26% 59.38% 75.26% 76.12% 82.88%
Interest Burden Percent
95.11% 96.00% 95.53% 95.16% 95.95% 26.38% 67.77% 74.31% 70.19% 77.44% 91.86%
Effective Tax Rate
23.81% 22.09% 21.35% 23.04% 21.43% 35.54% -29.56% 40.68% 24.61% 24.06% 16.98%
Return on Invested Capital (ROIC)
13.75% 13.61% 11.46% 13.91% 12.46% 2.40% 13.51% 8.13% 9.43% 9.31% 25.28%
ROIC Less NNEP Spread (ROIC-NNEP)
10.85% 10.00% -22.98% 23.35% -11.60% 0.40% 8.80% 5.82% 6.39% 7.82% 23.64%
Return on Net Nonoperating Assets (RNNOA)
1.17% 0.60% -0.15% -0.52% -0.06% 0.13% 3.17% 1.89% 1.98% 4.66% 13.10%
Return on Equity (ROE)
14.92% 14.22% 11.31% 13.39% 12.41% 2.52% 16.68% 10.02% 11.41% 13.97% 38.39%
Cash Return on Invested Capital (CROIC)
19.37% 18.11% 8.69% 7.94% 8.11% -47.10% -52.64% -54.65% -50.03% 1.41% 13.88%
Operating Return on Assets (OROA)
11.05% 10.72% 8.68% 10.59% 9.90% 2.30% 7.33% 9.71% 8.88% 9.07% 23.03%
Return on Assets (ROA)
7.98% 7.94% 6.47% 7.72% 7.47% 0.39% 6.42% 4.29% 4.69% 5.34% 17.53%
Return on Common Equity (ROCE)
14.92% 14.22% 11.31% 13.39% 12.41% 2.47% 16.33% 9.82% 11.19% 13.27% 36.56%
Return on Equity Simple (ROE_SIMPLE)
23.47% 22.30% 11.90% 0.00% 11.01% 8.36% 9.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
21 20 17 21 19 5.46 34 21 22 27 75
NOPAT Margin
11.10% 11.28% 9.69% 11.59% 11.11% 2.87% 16.37% 9.28% 10.28% 12.21% 33.57%
Net Nonoperating Expense Percent (NNEP)
2.89% 3.61% 34.44% -9.44% 24.07% 1.99% 4.71% 2.31% 3.04% 1.49% 1.64%
Return On Investment Capital (ROIC_SIMPLE)
- 2.62% - - - 0.46% 2.69% 1.63% 1.78% 2.19% 6.15%
Cost of Revenue to Revenue
60.69% 59.83% 61.48% 61.48% 58.89% 62.36% 60.33% 58.88% 58.41% 58.33% 59.07%
SG&A Expenses to Revenue
23.59% 24.26% 23.56% 22.74% 25.25% 24.06% 25.05% 23.69% 25.01% 25.12% 23.35%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
24.74% 25.69% 26.20% 23.46% 26.97% 33.18% 27.04% 25.47% 27.96% 25.60% 0.49%
Earnings before Interest and Taxes (EBIT)
26 26 21 27 24 7.57 26 35 30 35 90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
33 32 28 34 31 16 36 45 40 45 99
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.89 3.02 3.48 3.07 3.29 3.44 2.80 2.65 3.61 0.00 4.10
Price to Tangible Book Value (P/TBV)
7.28 7.27 8.45 7.29 7.55 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.30 2.54 2.96 2.65 3.07 3.15 2.57 2.39 3.06 0.00 3.49
Price to Earnings (P/E)
12.30 13.53 29.27 26.09 29.90 41.50 31.73 33.88 48.60 0.00 31.20
Dividend Yield
0.77% 0.71% 0.47% 0.55% 0.49% 0.65% 0.77% 0.81% 0.60% 0.60% 0.52%
Earnings Yield
8.13% 7.39% 3.42% 3.83% 3.34% 2.41% 3.15% 2.95% 2.06% 0.00% 3.20%
Enterprise Value to Invested Capital (EV/IC)
2.82 3.00 3.44 3.09 3.35 2.46 2.04 1.99 2.57 0.00 3.00
Enterprise Value to Revenue (EV/Rev)
2.33 2.55 2.97 2.64 3.05 3.76 3.23 2.99 3.62 0.00 3.96
Enterprise Value to EBITDA (EV/EBITDA)
8.75 9.57 16.71 14.88 17.09 24.64 20.69 18.45 22.17 0.00 15.26
Enterprise Value to EBIT (EV/EBIT)
10.22 11.19 21.39 19.08 22.01 33.82 28.60 25.50 30.76 0.00 18.42
Enterprise Value to NOPAT (EV/NOPAT)
11.93 12.99 27.43 24.16 27.89 42.64 31.01 30.13 36.82 0.00 23.89
Enterprise Value to Operating Cash Flow (EV/OCF)
15.85 18.14 20.70 20.52 22.87 33.93 37.35 33.98 44.02 0.00 42.42
Enterprise Value to Free Cash Flow (EV/FCFF)
14.92 17.01 40.41 39.85 42.12 0.00 0.00 0.00 0.00 0.00 21.46
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.25 0.24 0.24 0.24 0.23 0.78 0.81 0.75 0.74 0.72 0.59
Long-Term Debt to Equity
0.25 0.24 0.24 0.24 0.23 0.78 0.81 0.75 0.74 0.72 0.59
Financial Leverage
0.11 0.06 0.01 -0.02 0.00 0.32 0.36 0.33 0.31 0.60 0.55
Leverage Ratio
1.75 1.71 1.64 1.65 1.61 1.91 1.91 1.89 1.86 2.13 2.04
Compound Leverage Factor
1.67 1.64 1.57 1.57 1.55 0.50 1.29 1.40 1.31 1.65 1.87
Debt to Total Capital
19.99% 19.33% 19.38% 19.33% 18.46% 43.90% 44.78% 42.76% 42.57% 41.79% 37.20%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
19.99% 19.33% 19.38% 19.33% 18.46% 43.90% 44.78% 42.76% 42.57% 41.79% 37.20%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 2.19% 2.13% 2.16% 2.12% 3.48% 3.48%
Common Equity to Total Capital
80.01% 80.67% 80.62% 80.68% 81.54% 53.91% 53.09% 55.08% 55.31% 54.73% 59.33%
Debt to EBITDA
0.75 0.76 1.15 1.16 1.18 4.88 4.96 4.31 3.98 3.23 2.06
Net Debt to EBITDA
0.11 0.03 0.08 -0.04 -0.12 3.77 4.02 3.49 3.26 2.64 1.61
Long-Term Debt to EBITDA
0.75 0.76 1.15 1.16 1.18 4.88 4.96 4.31 3.98 3.23 2.06
Debt to NOPAT
1.02 1.03 1.88 1.89 1.93 8.44 7.43 7.04 6.62 5.21 3.23
Net Debt to NOPAT
0.15 0.04 0.13 -0.07 -0.20 6.53 6.02 5.71 5.42 4.26 2.52
Long-Term Debt to NOPAT
1.02 1.03 1.88 1.89 1.93 8.44 7.43 7.04 6.62 5.21 3.23
Altman Z-Score
5.35 5.57 6.12 5.66 6.04 3.50 3.18 3.20 3.74 0.00 4.67
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 2.04% 2.07% 2.05% 1.95% 4.98% 4.75%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.19 3.34 3.43 3.37 3.55 3.37 3.40 2.88 2.87 2.87 3.05
Quick Ratio
1.93 2.05 2.12 2.16 2.25 1.99 1.95 1.66 1.56 1.60 1.79
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-8.67 -14 -8.17 -10 -7.13 -464 -521 -551 -516 -60 92
Operating Cash Flow to CapEx
372.98% 554.60% 470.59% 436.92% 261.31% 130.05% 157.11% 389.51% 262.09% 268.24% 210.14%
Free Cash Flow to Firm to Interest Expense
-6.80 -13.82 -8.61 -7.77 -7.30 -83.15 -62.31 -61.09 -57.90 -7.54 12.55
Operating Cash Flow to Interest Expense
12.68 23.13 25.68 21.96 17.99 1.62 1.14 3.71 1.89 2.60 1.60
Operating Cash Flow Less CapEx to Interest Expense
9.28 18.96 20.22 16.93 11.10 0.38 0.41 2.76 1.17 1.63 0.84
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.78 0.75 0.73 0.71 0.70 0.58 0.59 0.61 0.65 0.57 0.57
Accounts Receivable Turnover
6.19 6.00 6.03 5.89 5.75 5.15 5.15 5.37 5.87 5.27 5.07
Inventory Turnover
4.38 4.38 4.43 4.73 4.53 4.33 4.23 4.37 4.44 4.36 4.16
Fixed Asset Turnover
5.87 5.61 5.49 5.42 5.28 5.31 5.31 5.35 5.62 5.83 5.92
Accounts Payable Turnover
7.10 6.87 7.03 6.65 6.64 6.39 6.74 6.27 6.50 6.36 6.75
Days Sales Outstanding (DSO)
58.95 60.88 60.52 62.00 63.53 70.88 70.82 67.92 62.22 69.30 72.05
Days Inventory Outstanding (DIO)
83.26 83.40 82.35 77.24 80.55 84.31 86.31 83.44 82.21 83.80 87.66
Days Payable Outstanding (DPO)
51.40 53.16 51.94 54.91 54.97 57.13 54.14 58.17 56.12 57.42 54.05
Cash Conversion Cycle (CCC)
90.81 91.13 90.92 84.33 89.11 98.05 103.00 93.19 88.31 95.67 105.67
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
616 627 629 616 642 1,096 1,184 1,188 1,181 1,182 1,168
Invested Capital Turnover
1.24 1.21 1.18 1.20 1.12 0.83 0.83 0.88 0.92 0.76 0.75
Increase / (Decrease) in Invested Capital
29 34 25 31 26 469 555 571 538 87 -17
Enterprise Value (EV)
1,739 1,878 2,165 1,901 2,151 2,699 2,417 2,365 3,030 0.00 3,502
Market Capitalization
1,717 1,872 2,155 1,907 2,167 2,259 1,920 1,889 2,557 0.00 3,089
Book Value per Share
$50.19 $52.15 $52.14 $52.43 $55.51 $54.30 $57.73 $58.95 $58.91 $58.14 $62.23
Tangible Book Value per Share
$19.89 $21.64 $21.49 $22.07 $24.20 ($11.44) ($12.66) ($10.31) ($9.19) ($8.79) ($2.99)
Total Capital
743 769 768 770 807 1,217 1,294 1,292 1,279 1,279 1,271
Total Debt
149 149 149 149 149 534 579 553 545 535 473
Total Long-Term Debt
149 149 149 149 149 534 579 553 545 535 473
Net Debt
22 6.24 9.97 -5.33 -16 413 470 448 446 438 369
Capital Expenditures (CapEx)
4.34 4.25 5.18 6.53 6.73 6.97 6.07 8.58 6.42 7.66 5.59
Debt-free, Cash-free Net Working Capital (DFCFNWC)
162 163 158 148 157 206 234 209 219 223 221
Debt-free Net Working Capital (DFNWC)
288 305 297 303 321 327 344 314 318 320 324
Net Working Capital (NWC)
288 305 297 303 321 327 344 314 318 320 324
Net Nonoperating Expense (NNE)
1.69 1.25 1.38 1.30 0.74 4.18 11 5.12 6.55 6.33 6.89
Net Nonoperating Obligations (NNO)
22 6.24 9.97 -5.33 -16 413 470 448 446 438 369
Total Depreciation and Amortization (D&A)
7.08 6.89 7.18 6.99 7.06 8.51 9.74 10 9.82 9.98 9.45
Debt-free, Cash-free Net Working Capital to Revenue
21.68% 22.16% 21.68% 20.58% 22.17% 28.65% 31.27% 26.50% 26.19% 25.67% 24.91%
Debt-free Net Working Capital to Revenue
38.70% 41.51% 40.73% 41.98% 45.47% 45.53% 45.95% 39.73% 37.97% 36.83% 36.63%
Net Working Capital to Revenue
38.70% 41.51% 40.73% 41.98% 45.47% 45.53% 45.95% 39.73% 37.97% 36.83% 36.63%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.60 $1.60 $1.34 $1.68 $1.54 $0.07 $1.83 $1.24 $1.26 $0.17 $5.56
Adjusted Weighted Average Basic Shares Outstanding
11.74M 11.79M 11.77M 11.85M 11.79M 11.94M 11.99M 12.07M 12.01M 12.04M 12.05M
Adjusted Diluted Earnings per Share
$1.58 $1.59 $1.33 $1.64 $1.53 $0.07 $1.81 $1.23 $1.25 $0.17 $5.55
Adjusted Weighted Average Diluted Shares Outstanding
11.93M 11.86M 11.85M 11.85M 11.90M 12.03M 12.06M 12.07M 12.05M 12.06M 12.06M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
11.90M 11.87M 11.85M 11.85M 12.08M 11.90M 12.07M 12.07M 12.12M 12.12M 12.11M
Normalized Net Operating Profit after Tax (NOPAT)
22 22 21 22 21 17 21 23 27 28 80
Normalized NOPAT Margin
12.09% 12.40% 11.72% 12.15% 12.46% 8.76% 10.24% 10.34% 12.50% 12.57% 35.61%
Pre Tax Income Margin
13.42% 13.72% 11.43% 14.20% 13.58% 1.05% 8.46% 11.75% 9.65% 12.28% 36.81%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
20.43 25.02 22.36 20.68 24.70 1.36 3.10 3.89 3.35 4.43 12.28
NOPAT to Interest Expense
16.07 19.75 18.10 16.07 19.38 0.98 4.07 2.29 2.51 3.41 10.29
EBIT Less CapEx to Interest Expense
17.03 20.85 16.90 15.65 17.81 0.11 2.38 2.94 2.63 3.46 11.52
NOPAT Less CapEx to Interest Expense
12.67 15.58 12.65 11.05 12.50 -0.27 3.34 1.33 1.79 2.45 9.53
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
9.46% 9.70% 18.55% 19.02% 19.52% 26.29% 23.83% 26.06% 29.06% 23.03% 15.19%
Augmented Payout Ratio
37.62% 37.64% 71.13% 62.57% 38.91% 53.19% 39.41% 43.23% 45.82% 28.55% 18.61%

Financials Breakdown Chart

Key Financial Trends

Standex International (NYSE: SXI) has shown a pattern of revenue growth with solid cash flow generation over the last four years (2023–2026 across Q1–Q2 of 2026). While profitability per quarter fluctuates, the company maintains a constructive balance sheet with meaningful cash flow from operations and a manageable debt load. Here are the top trends an investor should note, based on the quarterly statements provided:

  • Revenue trend upward with stabilization at higher levels. Across 2023–2026, quarterly operating revenue generally rose from the high $180s to the low $220s millions, with 2024–2025 periods often near $210–$222 million. This suggests SXI has moved to a higher-level revenue base over time.
  • Gross margins consistently around the 40% range. Total gross profit divided by total revenue has hovered roughly in the 38–42% band in most quarters, indicating stable gross profitability despite mix changes.
  • Operating cash flow remains positive and material. Net cash from continuing operating activities frequently exceeds $15–30 million per quarter (e.g., Q4 2024 and Q4 2025 both around $33 million; early 2026 quarters also solid), underscoring healthy cash generation from core operations.
  • Free cash flow has been positive in several periods. When you back out capital expenditures (PPE purchases) from cash flow from operations, SXI typically retains meaningful free cash flow in several quarters, supporting dividends and debt service.
  • Retained earnings and total equity have grown, supporting a stronger balance sheet. Retained earnings and total equity figures show multi-year accumulation, contributing to a solid equity base to back assets and financing needs.
  • Notable one-off acquisitions in 2025. The Q2 2025 investing activity shows a large acquisitions outflow (substantial negative investing cash flow), indicating a major strategic expansion in that quarter. This is a neutral-to-positive long-term sign depending on integration success and return on investment, but it does impact near-term cash flow and liquidity considerations.
  • Debt level remains meaningful but manageable. Long-term debt sits around mid-$500 millions in recent years, with total liabilities supported by a sizable equity base. This suggests leverage is present but has been historically manageable; watch for rising interest costs if rates trend higher.
  • Dividend policy has been steady and modest. Cash dividends per share have hovered in the $0.32–$0.34 range in recent quarters, indicating a disciplined payout strategy aligned with cash flow levels.
  • Cash balances can fluctuate with capital deployment. Cash and equivalents have varied across periods (e.g., around $97–122 million in 2025–2026 quarters), reflecting cash used for acquisitions, dividends, and debt activity, rather than a static liquidity cushion.
  • Profitability margins can compress during certain periods. While gross margins stay around 40%, operating and net income margins have fluctuated, with some quarters showing modest to low net income relative to revenue. This indicates episodic margin pressure or the impact of operating costs and non-cash items on quarterly results.
05/14/26 02:18 AM ETAI Generated. May Contain Errors.

Standex International Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Standex International's fiscal year ends in June. Their fiscal year 2025 ended on June 30, 2025.

Standex International's net income appears to be on an upward trend, with a most recent value of $57.68 million in 2025, rising from $54.74 million in 2015. The previous period was $73.07 million in 2024. Check out Standex International's forecast to explore projected trends and price targets.

Standex International's total operating income in 2025 was $93.55 million, based on the following breakdown:
  • Total Gross Profit: $315.25 million
  • Total Operating Expenses: $221.70 million

Over the last 10 years, Standex International's total revenue changed from $772.14 million in 2015 to $790.11 million in 2025, a change of 2.3%.

Standex International's total liabilities were at $827.29 million at the end of 2025, a 115.7% increase from 2024, and a 166.4% increase since 2015.

In the past 10 years, Standex International's cash and equivalents has ranged from $88.57 million in 2017 to $195.71 million in 2023, and is currently $104.54 million as of their latest financial filing in 2025.

Over the last 10 years, Standex International's book value per share changed from 27.54 in 2015 to 58.95 in 2025, a change of 114.0%.



Financial statements for NYSE:SXI last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners